We hypothesized that inhibiting activated Cdc42 in melanoma cells by inhibiting PI3K could inhibit activated Cdc42-driven phenotypes such as proliferation, 3D cell growth, invasion, and migration. This evidence concerns the gene CDC42 and melanoma.